Use of colonoscopy to screen asymptomatic adults for colorectal cancer DA Lieberman, DG Weiss, JH Bond, DJ Ahnen, H Garewal, WV Harford, ... New England Journal of Medicine 343 (3), 162-168, 2000 | 2359 | 2000 |
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon DA Lieberman, WV Harford, DJ Ahnen, D Provenzale, SJ Sontag, ... New England Journal of Medicine 345 (8), 555-560, 2001 | 825 | 2001 |
Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0© R Yadlapati, PJ Kahrilas, MR Fox, AJ Bredenoord, C Prakash Gyawali, ... Neurogastroenterology & Motility 33 (1), e14058, 2021 | 728 | 2021 |
Esophageal disorders Q Aziz, R Fass, CP Gyawali, H Miwa, JE Pandolfino, F Zerbib Gastroenterology 150 (6), 1368-1379, 2016 | 698 | 2016 |
Non‐erosive reflux disease (NERD)—acid reflux and symptom patterns SD Martinez, IB Malagon, HS Garewal, H Cui, R Fass Alimentary pharmacology & therapeutics 17 (4), 537-545, 2003 | 634 | 2003 |
Effectiveness of proton pump inhibitors in nonerosive reflux disease BB Dean, AD Gano Jr, K Knight, JJ Ofman, R Fass Clinical Gastroenterology and Hepatology 2 (8), 656-664, 2004 | 629 | 2004 |
Gastroesophageal reflux disease—should we adopt a new conceptual framework? R Fass, JJ Ofman Official journal of the American College of Gastroenterology| ACG 97 (8 …, 2002 | 554 | 2002 |
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain R Fass, MB Fennerty, JJ Ofman, IM Gralnek, C Johnson, E Camargo, ... Gastroenterology 115 (1), 42-49, 1998 | 525 | 1998 |
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease–where next? R Fass, M Shapiro, R Dekel, J Sewell Alimentary pharmacology & therapeutics 22 (2), 79-94, 2005 | 524 | 2005 |
Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome–results of two randomized, placebo‐controlled studies DA Drossman, WD Chey, JF Johanson, R Fass, C Scott, R Panas, R Ueno Alimentary pharmacology & therapeutics 29 (3), 329-341, 2009 | 471 | 2009 |
Nonerosive reflux disease—current concepts and dilemmas R Fass, BM Fennerty, N Vakil Official journal of the American College of Gastroenterology| ACG 96 (2 …, 2001 | 456 | 2001 |
Management of heartburn not responding to proton pump inhibitors R Fass, D Sifrim Gut 58 (2), 295-309, 2009 | 450 | 2009 |
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults–update 2004 D Armstrong, JK Marshall, N Chiba, R Enns, CA Fallone, R Fass, ... Canadian Journal of Gastroenterology and Hepatology 19 (1), 15-35, 2005 | 373 | 2005 |
Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics R Fass Journal of clinical gastroenterology 41 (2), 131-137, 2007 | 360 | 2007 |
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans R Fass, B Naliboff, L Higa, C Johnson, A Kodner, J Munakata, J Ngo, ... Gastroenterology 115 (6), 1363-1373, 1998 | 358 | 1998 |
Functional heartburn: the stimulus, the pain, and the brain R Fass, G Tougas Gut 51 (6), 885-892, 2002 | 345 | 2002 |
Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease R Fass Official journal of the American College of Gastroenterology| ACG 98, S2-S7, 2003 | 342 | 2003 |
Management of gastroesophageal reflux disease CP Gyawali, R Fass Gastroenterology 154 (2), 302-318, 2018 | 334 | 2018 |
Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsia H Mertz, R Fass, A Kodner, F Yan-Go, S Fullerton, EA Mayer The American journal of gastroenterology 93 (2), 160-165, 1998 | 313 | 1998 |
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: update KM Fock, NJ Talley, R Fass, KL Goh, P Katelaris, R Hunt, M Hongo, ... Journal of gastroenterology and hepatology 23 (1), 8-22, 2008 | 297 | 2008 |